Good morning :)
Place Order
Add to Watchlist

Onyx Biotec Ltd

ONYX

Onyx Biotec Ltd

ONYX
Health CarePharmaceuticals
SmallcapWith a market cap of ₹102 cr, stock is ranked 3,047
High RiskStock is 3.71x as volatile as Nifty
55.152.30% (-1.30)
55.152.30% (-1.30)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹102 cr, stock is ranked 3,047
High RiskStock is 3.71x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

Insufficient Data

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹102 cr, stock is ranked 3,047
High RiskStock is 3.71x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
4.13
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Onyx Biotec Ltd. is a pharmaceutical company focused on the manufacture, sale, and distribution of generic and proprietary pharmaceutical products, including sterile water for injection and various dry powder injections and syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2022FY 2023FY 2024TTM
Total Revenue39.6139.6153.88
Raw Materialssubtract21.3021.3036.17
Power & Fuel Costsubtract0.000.000.00
Employee Costsubtract10.4810.486.00
Selling & Administrative Expensessubtract1.761.762.08
Operating & Other expensessubtract1.461.461.16
Depreciation/Amortizationsubtract1.491.492.25
Interest & Other Itemssubtract0.570.572.16
Taxes & Other Itemssubtract0.700.701.02
EPS1.571.572.42
DPS0.000.000.00
Payout ratio0.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Onyx Biotec Ltd33.824.13
Sun Pharmaceutical Industries Ltd45.356.470.75%
Cipla Ltd28.514.380.89%
Torrent Pharmaceuticals Ltd68.4516.540.84%

Price Comparison

Compare ONYX with any stock or ETF
Compare ONYX with any stock or ETF
ONYX
Loading...

Shareholdings

Promoter Holdings Trend

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding65.10%0.00%3.29%8.72%22.89%

Dec 1899

Shareholding History

Dec '998.72%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ONYX has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Spotlight
NSE SME Onyx Biotec slips on debut

The scrip was listed at Rs 54.05, a discount of 11.39% over the initial public offer (IPO) price. The stock was currently frozen at its upper limit of 5% compared to its listing price. The counter hit a high of Rs 56.75 and a low of Rs 51.45. About 6.52 lakh shares of the company changed hands at the counter. Onyx Biotec's IPO was subscribed 184.60 times. The issue opened for bidding on 13 November 2024 and it closed on 18 November 2024. The price band of the IPO was set at Rs 58 to Rs 61 per share. The IPO comprised fresh issue of 48,10,000 shares. The promoter and promoter group shareholding diluted to 65.10% from 88.60% pre-IPO. The company intends to utilize the net proceeds for up gradation of existing manufacturing unit I to manufacture large volume parental for intravenous use, setting up a high-speed cartooning packaging line at existing manufacturing unit II for dry powder injections, prepayment or repayment of all or a portion of certain loans availed by company and for general corporate purpose. Ahead of the IPO, Onyx Biotec on 12 November 2024, raised Rs 8.33 crore from anchor investors. The board allotted 13.66 lakh shares at Rs 61 per share to 3 anchor investor. Onyx Biotec is a pharmaceutical company providing sterile water for injections. The company currently manufactures sterile water for injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of dry powder injections and dry syrups for both the Indian and overseas markets. The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift. As of 31 July 2024, the company had 175 employees on payroll The company recorded revenue from operations of Rs 10.52 crore and net profit of Rs 1.30 crore for the period as on 31 May 2024. Powered by Capital Market - Live

2 weeks agoCapital Market - Live